The field of cancer research has increasingly focused on the metabolic underpinnings of tumorigenesis, recognizing how the reprogramming of cellular energy ...

Drug-drug interactions (DDIs) remain a critical challenge in both clinical practice and the drug discovery process, given their potential to produce unforeseen adverse effects and compromise patient ...

Welcome to this recent eBook, providing you with foremost and comprehensive insights on drug discovery in various research fields. This publication not only features advanced tools for drug discovery, ...

The use of artificial intelligence (AI) to develop new drugs is in its infancy. Nevertheless, AI-designed drugs have been entering the early phases of clinical trials over the past couple of years.

U.S. Food and Drug Administration (FDA) advisory committees play a key role in evaluating the efficacy and safety of new drugs. They include open public hearing sessions, whereby patients, clinicians, ...

The field of oncology has witnessed remarkable progress in the treatment of solid tumors, yet the quest for optimal therapeutic outcomes remains a formidable challenge. Current clinical evidence ...